State NY
Clinical Trials in New York
Recruiting clinical trials with at least one study location in New York. Data updated daily from ClinicalTrials.gov.
Top Conditions in New York
NCT06662500 N/A
Recruiting
FORWARD CAD IDE Study
Condition
Coronary Arterial Disease (CAD)
Enrollment
408 pts
Location
United States, United Kingdom
Sponsor
Shockwave Medical, Inc.
NCT07217171 Phase 1
Recruiting
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 ...
Condition
Bladder Cancer
Enrollment
160 pts
Location
United States
Sponsor
EvolveImmune United, Inc
NCT06633016 Phase 2
Recruiting
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPL...
Condition
Major Depressive Disorder
Enrollment
230 pts
Location
United States
Sponsor
Autobahn Therapeutics, Inc.
NCT07172516 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associat...
Condition
Bipolar Disorder
Enrollment
400 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
NCT04060017 Phase 2
Recruiting
Early Treatment of Language Impairment in Young Children With Autism Spectrum Di...
Condition
Autism Spectrum Disorder
Enrollment
80 pts
Location
United States
Sponsor
Southwest Autism Research & Re
NCT06463340 Phase 1
Recruiting
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Condition
Advanced Solid Tumor
Enrollment
52 pts
Location
United States, Canada
Sponsor
Schrödinger, Inc.
NCT06673017 Phase 1
Recruiting
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
26 pts
Location
United States
Sponsor
PanTher Therapeutics
NCT05720117 Phase 1
Recruiting
A Study of PYX-201 in Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
330 pts
Location
United States, Belgium, Spain
Sponsor
Pyxis Oncology, Inc
NCT06903702 Phase 2
Recruiting
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65...
Condition
Acute Myeloid Leukemia
Enrollment
100 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06780709 N/A
Recruiting
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NM...
Condition
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Enrollment
20 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT07285694 Phase 1, Phase 2
Recruiting
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resis...
Condition
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Enrollment
190 pts
Location
United States
Sponsor
Arsenal Biosciences, Inc.
NCT06360354 Phase 1
Recruiting
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participa...
Condition
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Enrollment
350 pts
Location
United States, Australia, Belgium
Sponsor
Amgen
NCT06410144 N/A
Recruiting
Chronic Kidney Disease-Education (CKD-EDU)
Condition
Chronic Kidney Diseases
Enrollment
326 pts
Location
United States
Sponsor
University of Rochester
NCT07076238 N/A
Recruiting
Biomarkers of Phage Treatment Response in NTM and Other Infections
Condition
Nontuberculous Mycobacterial Lung Disease
Enrollment
100 pts
Location
United States
Sponsor
NYU Langone Health
NCT06444347 N/A
Recruiting
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
Condition
Hiatal Hernia
Enrollment
200 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT06452355 N/A
Recruiting
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum...
Condition
Postpartum Hemorrhage
Enrollment
72 pts
Location
United States
Sponsor
KOKO Medical Inc.
NCT05933148 N/A
Recruiting
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depressio...
Condition
Major Depressive Disorder
Enrollment
80 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT06881784 Phase 3
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301...
Condition
NSCLC (Non-small Cell Lung Cancer)
Enrollment
420 pts
Location
United States, Australia, Belgium
Sponsor
Revolution Medicines, Inc.
NCT07088835 N/A
Recruiting
SeizEAR Safety Study
Condition
Epilepsy
Enrollment
15 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo
NCT05706558 N/A
Recruiting
Retrospective Review of Esophageal Cancer at MSKCC
Condition
Esophageal Cancer
Enrollment
4,000 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06957314 N/A
Recruiting
A Study of Hospital-at-Home for People Receiving Tarlatamab
Condition
Small-cell Lung Cancer
Enrollment
70 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06055920 N/A
Recruiting
The PEERLESS II Study
Condition
Pulmonary Embolism
Enrollment
1,200 pts
Location
United States, Belgium, Canada
Sponsor
Inari Medical
NCT07184996 Phase 3
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Partic...
Condition
Ulcerative Colitis
Enrollment
980 pts
Location
United States, Canada, Georgia
Sponsor
Sanofi
NCT07102342 Phase 1
Recruiting
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibilit...
Condition
Parkinson Disease
Enrollment
5 pts
Location
United States
Sponsor
iRegene Therapeutics Co., Ltd.
NCT07103746 Phase 2
Recruiting
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Condition
Autoimmune Disorders
Enrollment
30 pts
Location
United States
Sponsor
National Institute of Allergy